HUAMINWANGHUAMIN WANG9082WANG, HUAMINProfessorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson1515 Holcombe BlvdHouston77030-4009TXAuthorship 1676787Authorship 1697274Authorship 1716672Authorship 1719487Authorship 1739025Authorship 1754001Authorship 1765551Authorship 1789112Authorship 1802494Authorship 1804118Authorship 1805076Authorship 18125610Authorship 1812979Authorship 18186011Authorship 1819199Authorship 1837655Authorship 1844595Authorship 1846367Authorship 1849127Authorship 1849807Authorship 18501710Authorship 1850856Authorship 1876729Authorship 1884832Authorship 18895016Authorship 1893402Authorship 19155013Authorship 1915597Authorship 1916506Authorship 1927876Authorship 19295012Authorship 1930803Authorship 1933607Authorship 1935333Authorship 19375811Authorship 1960063Authorship 19619068597121Strobel HW, Kawashima H, Geng J, Sequeira D, Bergh A, Hodgson AV, Wang H, Shen SToxicology lettersExpression of multiple forms of brain cytochrome P450. Toxicol Lett. 1995 Dec; 82-83:639-43.Toxicol Lett1995-12-01T00:00:001995Expression of multiple forms of brain cytochrome P450.12907597Wang H, Wang H, Shen W, Huang H, Hu L, Ramdas L, Zhou YH, Liao WS, Fuller GN, Zhang WCancer researchInsulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. Cancer Res. 2003 Aug 01; 63(15):4315-21.Cancer Res2003-08-01T00:00:002003Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes.15022276Hao X, Sun B, Hu L, L?hdesm?ki H, Dunmire V, Feng Y, Zhang SW, Wang H, Wu C, Wang H, Fuller GN, Symmans WF, Shmulevich I, Zhang WCancerDifferential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. Cancer. 2004 Mar 15; 100(6):1110-22.Cancer2004-03-15T00:00:002004Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis.17511115Tseng JF, Pisters PW, Lee JE, Wang H, Gomez HF, Sun CC, Evans DBSurgeryThe learning curve in pancreatic surgery. Surgery. 2007 May; 141(5):694-701.Surgery2007-05-01T00:00:002007The learning curve in pancreatic surgery.18834221Sanchez AA, Wu TT, Prieto VG, Rashid A, Hamilton SR, Wang HArchives of pathology & laboratory medicineComparison of primary and metastatic malignant melanoma of the esophagus: clinicopathologic review of 10 cases. Arch Pathol Lab Med. 2008 Oct; 132(10):1623-9.Arch Pathol Lab Med2008-10-01T00:00:002008Comparison of primary and metastatic malignant melanoma of the esophagus: clinicopathologic review of 10 cases.20660371Lee SO, Abdelrahim M, Yoon K, Chintharlapalli S, Papineni S, Kim K, Wang H, Safe SCancer researchInactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth. Cancer Res. 2010 Sep 01; 70(17):6824-36.Cancer Res2010-07-21T00:00:002010Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth.20727893Wei D, Wang L, Kanai M, Jia Z, Le X, Li Q, Wang H, Xie KGastroenterologyKLF4a up-regulation promotes cell cycle progression and reduces survival time of patients with pancreatic cancer. Gastroenterology. 2010 Dec; 139(6):2135-45.Gastroenterology2010-08-19T00:00:002010KLF4a up-regulation promotes cell cycle progression and reduces survival time of patients with pancreatic cancer.20922806Song X, Wang H, Logsdon CD, Rashid A, Fleming JB, Abbruzzese JL, Gomez HF, Evans DB, Wang HCancerOverexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma. Cancer. 2011 Feb 15; 117(4):734-43.Cancer2010-10-04T00:00:002010Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma.21057542Yang L, Wang H, Kornblau SM, Graber DA, Zhang N, Matthews JA, Wang M, Weber DM, Thomas SK, Shah JJ, Zhang L, Lu G, Zhao M, Muddasani R, Yoo SY, Baggerly KA, Orlowski RZOncogeneEvidence of a role for the novel zinc-finger transcription factor ZKSCAN3 in modulating Cyclin D2 expression in multiple myeloma. Oncogene. 2011 Mar 17; 30(11):1329-40.Oncogene2010-11-08T00:00:002010Evidence of a role for the novel zinc-finger transcription factor ZKSCAN3 in modulating Cyclin D2 expression in multiple myeloma.22340593Katayama H, Wang J, Treekitkarnmongkol W, Kawai H, Sasai K, Zhang H, Wang H, Adams HP, Jiang S, Chakraborty SN, Suzuki F, Arlinghaus RB, Liu J, Mobley JA, Grizzle WE, Wang H, Sen SCancer cellAurora kinase-A inactivates DNA damage-induced apoptosis and spindle assembly checkpoint response functions of p73. Cancer Cell. 2012 Feb 14; 21(2):196-211.Cancer Cell2012-02-14T00:00:002012Aurora kinase-A inactivates DNA damage-induced apoptosis and spindle assembly checkpoint response functions of p73.23041324Huang H, Liu Y, Daniluk J, Gaiser S, Chu J, Wang H, Li ZS, Logsdon CD, Ji BGastroenterologyActivation of nuclear factor-?B in acinar cells increases the severity of pancreatitis in mice. Gastroenterology. 2013 Jan; 144(1):202-10.Gastroenterology2012-10-03T00:00:002012Activation of nuclear factor-?B in acinar cells increases the severity of pancreatitis in mice.23422726Abd-Elgaliel WR, Cruz-Monserrate Z, Wang H, Logsdon CD, Tung CHJournal of controlled release : official journal of the Controlled Release SocietyPancreatic cancer-associated Cathepsin E as a drug activator. J Control Release. 2013 May 10; 167(3):221-7.J Control Release2013-02-26T00:00:002013Pancreatic cancer-associated Cathepsin E as a drug activator.23704197Jiang ZQ, Varadhachary G, Wang X, Kopetz S, Lee JE, Wang H, Shroff R, Katz M, Wolff RA, Fleming J, Overman MJAnnals of oncology : official journal of the European Society for Medical OncologyA retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapy. Ann Oncol. 2013 Sep; 24(9):2349-53.Ann Oncol2013-05-22T00:00:002013A retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapy.23991810Tzeng CW, Balachandran A, Ahmad M, Lee JE, Krishnan S, Wang H, Crane CH, Wolff RA, Varadhachary GR, Pisters PW, Aloia TA, Vauthey JN, Fleming JB, Katz MHHPB : the official journal of the International Hepato Pancreato Biliary AssociationSerum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer. HPB (Oxford). 2014 May; 16(5):430-8.HPB (Oxford)2013-08-29T00:00:002013Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer.24111684Chatterjee D, Katz MH, Rashid A, Estrella JS, Wang H, Varadhachary GR, Wolff RA, Lee JE, Pisters PW, Abbruzzese JL, Fleming JB, Wang HHistopathologyPancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma. Histopathology. 2013 Dec; 63(6):841-51.Histopathology2013-09-20T00:00:002013Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma.24129826Tran Cao HS, Balachandran A, Wang H, Nogueras-Gonz?lez GM, Bailey CE, Lee JE, Pisters PW, Evans DB, Varadhachary G, Crane CH, Aloia TA, Vauthey JN, Fleming JB, Katz MHJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractRadiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer. J Gastrointest Surg. 2014 Feb; 18(2):269-78; discussion 278.J Gastrointest Surg2013-10-16T00:00:002013Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer.GI Medical OncologySurgical OncologyMD AndersonJEFFREY ELEEJEFFREY E LEE8460LEE, JEFFREY EProfessorJASON BFLEMINGJASON B FLEMING8742FLEMING, JASON BProfessor4.764930.00671733643research areas3.7760.0155924148coauthor of243.06328.995960similar to11181selected publicationsANIRBANMAITRAANIRBAN MAITRA9915MAITRA, ANIRBANProfessorJAFFER AAJANIJAFFER A AJANI8473AJANI, JAFFER AProfessorGAURI RVARADHACHARYGAURI R VARADHACHARY9083VARADHACHARY, GAURI RProfessorMATTHEW HAROLDKATZMATTHEW HAROLD KATZ9338KATZ, MATTHEW HAROLDAssociate ProfessorASIFRASHIDASIF RASHID8829RASHID, ASIFProfessorAuthorship 2175971Authorship 2187161Authorship 2189942Authorship 2195172Authorship 2195501Authorship 2222481Authorship 2230185Authorship 2235602Authorship 2240364Authorship 2244212Authorship 2248882Authorship 2250593Authorship 2259007Authorship 2260011Authorship 2264643Authorship 2268673Authorship 2271863Authorship 2272815Authorship 2278003Authorship 22782710Authorship 2282559Authorship 2283005Authorship 2287117Authorship 2293356Authorship 2296847Authorship 23074915Authorship 2308054Authorship 23084814Authorship 2308701Authorship 23102612Authorship 2312607Authorship 23234811Authorship 2324292Authorship 2325362Authorship 2330838Authorship 2339229Authorship 2339818Authorship 23420010Authorship 2346587Authorship 235030179264551Wang H, Strobel HWArchives of biochemistry and biophysicsRegulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli. Arch Biochem Biophys. 1997 Aug 15; 344(2):365-72.Arch Biochem Biophys1997-08-15T00:00:001997Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli.10892895Kelly PA, Wang H, Napoli KL, Kahan BD, Strobel HWEuropean journal of drug metabolism and pharmacokineticsMetabolism of cyclosporine by cytochromes P450 3A9 and 3A4. Eur J Drug Metab Pharmacokinet. 1999 Oct-Dec; 24(4):321-8.Eur J Drug Metab Pharmacokinet1999-10-01T00:00:001999Metabolism of cyclosporine by cytochromes P450 3A9 and 3A4.11770905Wang H, Wang H, Zhang W, Fuller GNBrain pathology (Zurich, Switzerland)Tissue microarrays: applications in neuropathology research, diagnosis, and education. Brain Pathol. 2002 Jan; 12(1):95-107.Brain Pathol2002-01-01T00:00:002002Tissue microarrays: applications in neuropathology research, diagnosis, and education.12484570Fuller CE, Wang H, Zhang W, Fuller GN, Perry AJournal of neuropathology and experimental neurologyHigh-throughput molecular profiling of high-grade astrocytomas: the utility of fluorescence in situ hybridization on tissue microarrays (TMA-FISH). J Neuropathol Exp Neurol. 2002 Dec; 61(12):1078-84.J Neuropathol Exp Neurol2002-12-01T00:00:002002High-throughput molecular profiling of high-grade astrocytomas: the utility of fluorescence in situ hybridization on tissue microarrays (TMA-FISH).12521397Wang H, Medeiros LJ, Jones DClinical lymphomaSubcutaneous panniculitis-like T-cell lymphoma. Clin Lymphoma. 2002 Dec; 3(3):181-3.Clin Lymphoma2002-12-01T00:00:002002Subcutaneous panniculitis-like T-cell lymphoma.15184909Wang H, Wang H, Zhang W, Huang HJ, Liao WS, Fuller GNLaboratory investigation; a journal of technical methods and pathologyAnalysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas. Lab Invest. 2004 Aug; 84(8):941-51.Lab Invest2004-08-01T00:00:002004Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas.16899607Wang KL, Wu TT, Resetkova E, Wang H, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Hamilton SR, Albarracin CTClinical cancer research : an official journal of the American Association for Cancer ResearchExpression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin Cancer Res. 2006 Aug 01; 12(15):4598-604.Clin Cancer Res2006-08-01T00:00:002006Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.16951195Mann AP, Verma A, Sethi G, Manavathi B, Wang H, Fok JY, Kunnumakkara AB, Kumar R, Aggarwal BB, Mehta KCancer researchOverexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway. Cancer Res. 2006 Sep 01; 66(17):8788-95.Cancer Res2006-09-01T00:00:002006Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway.17079475Verma A, Wang H, Manavathi B, Fok JY, Mann AP, Kumar R, Mehta KCancer researchIncreased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis. Cancer Res. 2006 Nov 01; 66(21):10525-33.Cancer Res2006-11-01T00:00:002006Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis.17304533Baruch AC, Wang H, Staerkel GA, Evans DB, Hwang RF, Krishnamurthy SDiagnostic cytopathologyImmunocytochemical study of the expression of mesothelin in fine-needle aspiration biopsy specimens of pancreatic adenocarcinoma. Diagn Cytopathol. 2007 Mar; 35(3):143-7.Diagn Cytopathol2007-03-01T00:00:002007Immunocytochemical study of the expression of mesothelin in fine-needle aspiration biopsy specimens of pancreatic adenocarcinoma.18078366Miller DV, Wang H, Wang H, Fealey ME, Tazelaar HDPediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology SocietyBeta-catenin mutations do not contribute to cardiac fibroma pathogenesis. Pediatr Dev Pathol. 2008 Jul-Aug; 11(4):291-4.Pediatr Dev Pathol2007-12-13T00:00:002007Beta-catenin mutations do not contribute to cardiac fibroma pathogenesis.18246408Li JY, Wang H, May S, Song X, Fueyo J, Fuller GN, Wang HJournal of neuro-oncologyConstitutive activation of c-Jun N-terminal kinase correlates with histologic grade and EGFR expression in diffuse gliomas. J Neurooncol. 2008 May; 88(1):11-7.J Neurooncol2008-02-02T00:00:002008Constitutive activation of c-Jun N-terminal kinase correlates with histologic grade and EGFR expression in diffuse gliomas.18373644Wang H, Arun BK, Wang H, Fuller GN, Zhang W, Middleton LP, Sahin AAThe breast journalIGFBP2 and IGFBP5 overexpression correlates with the lymph node metastasis in T1 breast carcinomas. Breast J. 2008 May-Jun; 14(3):261-7.Breast J2008-03-27T00:00:002008IGFBP2 and IGFBP5 overexpression correlates with the lymph node metastasis in T1 breast carcinomas.18381937Verma A, Guha S, Wang H, Fok JY, Koul D, Abbruzzese J, Mehta KClinical cancer research : an official journal of the American Association for Cancer ResearchTissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells. Clin Cancer Res. 2008 Apr 01; 14(7):1997-2005.Clin Cancer Res2008-04-01T00:00:002008Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells.18466869Mortenson MM, Katz MH, Tamm EP, Bhutani MS, Wang H, Evans DB, Fleming JBAmerican journal of surgeryCurrent diagnosis and management of unusual pancreatic tumors. Am J Surg. 2008 Jul; 196(1):100-13.Am J Surg2008-05-07T00:00:002008Current diagnosis and management of unusual pancreatic tumors.18640929Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Abdalla E, Wang H, Staerkel GA, Lee JH, Ross WA, Tamm EP, Bhosale PR, Krishnan S, Das P, Ho L, Xiong H, Abbruzzese JL, Evans DBJournal of clinical oncology : official journal of the American Society of Clinical OncologyPreoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol. 2008 Jul 20; 26(21):3487-95.J Clin Oncol2008-07-20T00:00:002008Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head.18676832Tong Z, Kunnumakkara AB, Wang H, Matsuo Y, Diagaradjane P, Harikumar KB, Ramachandran V, Sung B, Chakraborty A, Bresalier RS, Logsdon C, Aggarwal BB, Krishnan S, Guha SCancer researchNeutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer. Cancer Res. 2008 Aug 01; 68(15):6100-8.Cancer Res2008-08-01T00:00:002008Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer.18710598Akkiprik M, Feng Y, Wang H, Chen K, Hu L, Sahin A, Krishnamurthy S, Ozer A, Hao X, Zhang WBreast cancer research : BCRMultifunctional roles of insulin-like growth factor binding protein 5 in breast cancer. Breast Cancer Res. 2008; 10(4):212.Breast Cancer Res2008-08-11T00:00:002008Multifunctional roles of insulin-like growth factor binding protein 5 in breast cancer.18829536Ramachandran V, Arumugam T, Wang H, Logsdon CDCancer researchAnterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. Cancer Res. 2008 Oct 01; 68(19):7811-8.Cancer Res2008-10-01T00:00:002008Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival.19935793Overman MJ, Pozadzides J, Kopetz S, Wen S, Abbruzzese JL, Wolff RA, Wang HBritish journal of cancerImmunophenotype and molecular characterisation of adenocarcinoma of the small intestine. Br J Cancer. 2010 Jan 05; 102(1):144-50.Br J Cancer2009-11-24T00:00:002009Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine.19967449Higgins RJ, Dickinson PJ, LeCouteur RA, Bollen AW, Wang H, Wang H, Corely LJ, Moore LM, Zang W, Fuller GNJournal of neuro-oncologySpontaneous canine gliomas: overexpression of EGFR, PDGFRalpha and IGFBP2 demonstrated by tissue microarray immunophenotyping. J Neurooncol. 2010 May; 98(1):49-55.J Neurooncol2009-12-05T00:00:002009Spontaneous canine gliomas: overexpression of EGFR, PDGFRalpha and IGFBP2 demonstrated by tissue microarray immunophenotyping.20162463Katz MH, Varadhachary GR, Fleming JB, Wolff RA, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Sun CC, Wang H, Crane CH, Lee JH, Tamm EP, Abbruzzese JL, Evans DBAnnals of surgical oncologySerum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation. Ann Surg Oncol. 2010 Jul; 17(7):1794-801.Ann Surg Oncol2010-02-17T00:00:002010Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation.20459550Rubbia-Brandt L, Lauwers GY, Wang H, Majno PE, Tanabe K, Zhu AX, Brezault C, Soubrane O, Abdalla EK, Vauthey JN, Mentha G, Terris BHistopathologySinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology. 2010 Mar; 56(4):430-9.Histopathology2010-03-01T00:00:002010Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis.21074697Abadeer RA, Fleming JB, Deavers MT, Rashid A, Evans DB, Wang HAnnals of diagnostic pathologyMetastatic adult granulosa cell tumor mimicking a benign pancreatic cyst. Ann Diagn Pathol. 2010 Dec; 14(6):457-60.Ann Diagn Pathol2010-02-11T00:00:002010Metastatic adult granulosa cell tumor mimicking a benign pancreatic cyst.21701930Kim MP, Truty MJ, Choi W, Kang Y, Chopin-Lally X, Gallick GE, Wang H, McConkey DJ, Hwang R, Logsdon C, Abbruzzesse J, Fleming JBAnnals of surgical oncologyMolecular profiling of direct xenograft tumors established from human pancreatic adenocarcinoma after neoadjuvant therapy. Ann Surg Oncol. 2012 Jul; 19 Suppl 3:S395-403.Ann Surg Oncol2011-06-24T00:00:002011Molecular profiling of direct xenograft tumors established from human pancreatic adenocarcinoma after neoadjuvant therapy.21976550Chang DZ, Ma Y, Ji B, Wang H, Deng D, Liu Y, Abbruzzese JL, Liu YJ, Logsdon CD, Hwu PClinical cancer research : an official journal of the American Association for Cancer ResearchMast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma. Clin Cancer Res. 2011 Nov 15; 17(22):7015-23.Clin Cancer Res2011-10-05T00:00:002011Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma.22028089Chatterjee D, Katz MH, Rashid A, Varadhachary GR, Wolff RA, Wang H, Lee JE, Pisters PW, Vauthey JN, Crane C, Gomez HF, Abbruzzese JL, Fleming JB, Wang HCancerHistologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome. Cancer. 2012 Jun 15; 118(12):3182-90.Cancer2011-10-25T00:00:002011Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome.22068166Cruz-Monserrate Z, Abd-Elgaliel WR, Grote T, Deng D, Ji B, Arumugam T, Wang H, Tung CH, Logsdon CDGutDetection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models. Gut. 2012 Sep; 61(9):1315-22.Gut2011-11-07T00:00:002011Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models.22180096Wang J, Estrella JS, Peng L, Rashid A, Varadhachary GR, Wang H, Lee JE, Pisters PW, Vauthey JN, Katz MH, Gomez HF, Evans DB, Abbruzzese JL, Fleming JB, Wang HCancerHistologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. Cancer. 2012 Aug 01; 118(15):3801-11.Cancer2011-12-16T00:00:002011Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation.22475564Chang DZ, Ma Y, Ji B, Liu Y, Hwu P, Abbruzzese JL, Logsdon C, Wang HJournal of hematology & oncologyIncreased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression. J Hematol Oncol. 2012 Apr 04; 5:15.J Hematol Oncol2012-04-04T00:00:002012Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression.22561135Wang H, Zhao QAnnals of diagnostic pathologyPathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with better prognosis. Ann Diagn Pathol. 2012 Oct; 16(5):427.Ann Diagn Pathol2012-05-04T00:00:002012Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with better prognosis.22644446Thomas RM, Truty MJ, Nogueras-Gonzalez GM, Fleming JB, Vauthey JN, Pisters PW, Lee JE, Rice DC, Hofstetter WL, Wolff RA, Varadhachary GR, Wang H, Katz MHJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractSelective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection. J Gastrointest Surg. 2012 Sep; 16(9):1696-704.J Gastrointest Surg2012-05-30T00:00:002012Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection.22665577Weng S, Wang H, Chen W, Katz MH, Chatterjee D, Lee JE, Pisters PW, Gomez HF, Abbruzzese JL, Fleming JB, Wang HCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyOverexpression of protein phosphatase 4 correlates with poor prognosis in patients with stage II pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2012 Aug; 21(8):1336-43.Cancer Epidemiol Biomarkers Prev2012-06-04T00:00:002012Overexpression of protein phosphatase 4 correlates with poor prognosis in patients with stage II pancreatic ductal adenocarcinoma.23149995Overman M, Wang H, Varadhachary GRJAMAAdjuvant chemotherapy for resected periampullary adenocarcinoma. JAMA. 2012 Nov 14; 308(18):1855; author reply 1855-6.JAMA2012-11-14T00:00:002012Adjuvant chemotherapy for resected periampullary adenocarcinoma.23388125Lewis GH, Wang H, Bellizzi AM, Klein AP, Askin FB, Schwartz LE, Schulick RD, Wolfgang CL, Cameron JL, O'Reilly EM, Yu KH, Hruban RHThe American journal of surgical pathologyPrognosis of minimally invasive carcinoma arising in mucinous cystic neoplasms of the pancreas. Am J Surg Pathol. 2013 Apr; 37(4):601-5.Am J Surg Pathol2013-04-01T00:00:002013Prognosis of minimally invasive carcinoma arising in mucinous cystic neoplasms of the pancreas.24139211Zenali M, Overman MJ, Rashid A, Broaddus RB, Wang H, Katz MH, Fleming JB, Abbruzzese JL, Wang HHuman pathologyClinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma. Hum Pathol. 2013 Dec; 44(12):2792-8.Hum Pathol2013-10-15T00:00:002013Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma.24209743Jun S, Lee S, Kim HC, Ng C, Schneider AM, Ji H, Ying H, Wang H, DePinho RA, Park JICell reportsPAF-mediated MAPK signaling hyperactivation via LAMTOR3 induces pancreatic tumorigenesis. Cell Rep. 2013 Oct 31; 5(2):314-22.Cell Rep2013-10-31T00:00:002013PAF-mediated MAPK signaling hyperactivation via LAMTOR3 induces pancreatic tumorigenesis.24418153Shroff S, Rashid A, Wang H, Katz MH, Abbruzzese JL, Fleming JB, Wang HHuman pathologySOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms. Hum Pathol. 2014 Mar; 45(3):456-63.Hum Pathol2013-10-19T00:00:002013SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms.24520096Gong J, Xie J, Bedolla R, Rivas P, Chakravarthy D, Freeman JW, Reddick R, Kopetz S, Peterson A, Wang H, Fischer SM, Kumar APClinical cancer research : an official journal of the American Association for Cancer ResearchCombined targeting of STAT3/NF-?B/COX-2/EP4 for effective management of pancreatic cancer. Clin Cancer Res. 2014 Mar 01; 20(5):1259-73.Clin Cancer Res2014-02-11T00:00:002014Combined targeting of STAT3/NF-?B/COX-2/EP4 for effective management of pancreatic cancer.24614108Koay EJ, Truty MJ, Cristini V, Thomas RM, Chen R, Chatterjee D, Kang Y, Bhosale PR, Tamm EP, Crane CH, Javle M, Katz MH, Gottumukkala VN, Rozner MA, Shen H, Lee JE, Wang H, Chen Y, Plunkett W, Abbruzzese JL, Wolff RA, Varadhachary GR, Ferrari M, Fleming JBThe Journal of clinical investigationTransport properties of pancreatic cancer describe gemcitabine delivery and response. J Clin Invest. 2014 Apr; 124(4):1525-36.J Clin Invest2014-03-10T00:00:002014Transport properties of pancreatic cancer describe gemcitabine delivery and response.Authorship 2389621Authorship 2425071Authorship 2467084Authorship 2482496Authorship 2485951Authorship 2488985Authorship 2496684Authorship 2498765Authorship 2501363Authorship 2503952Authorship 2513922Authorship 2518413Authorship 2523634Authorship 2525049Authorship 2525175Authorship 2526255Authorship 2532722Authorship 2544653Authorship 2545837Authorship 2546672Authorship 25559710Authorship 2556605Authorship 2565153Authorship 25653915Authorship 25687012Authorship 2573275Authorship 25789425Authorship 2580553Authorship 2580748Authorship 25837311Authorship 2587584Authorship 25943114Authorship 2594512Authorship 25969314Authorship 2598127Authorship 2612295Authorship 26144611Authorship 261461108660328Wang H, Kawashima H, Strobel HWBiochemical and biophysical research communicationscDNA cloning of a novel CYP3A from rat brain. Biochem Biophys Res Commun. 1996 Apr 05; 221(1):157-62.Biochem Biophys Res Commun1996-04-05T00:00:001996cDNA cloning of a novel CYP3A from rat brain.11129951Wang H, Napoli KL, Strobel HWMolecular and cellular biochemistryCytochrome P450 3A9 catalyzes the metabolism of progesterone and other steroid hormones. Mol Cell Biochem. 2000 Oct; 213(1-2):127-35.Mol Cell Biochem2000-10-01T00:00:002000Cytochrome P450 3A9 catalyzes the metabolism of progesterone and other steroid hormones.15686601Lee EJ, Mircean C, Shmulevich I, Wang H, Liu J, Niemist? A, Kavanagh JJ, Lee JH, Zhang WMolecular cancerInsulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion. Mol Cancer. 2005 Feb 02; 4(1):7.Mol Cancer2005-02-02T00:00:002005Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion.16700616Wang H, Wang H, Zhang W, Fuller GNTechnology in cancer research & treatmentOverexpression of IGFBP5, but not IGFBP3, correlates with the histologic grade of human diffuse glioma: a tissue microarray and immunohistochemical study. Technol Cancer Res Treat. 2006 Jun; 5(3):195-9.Technol Cancer Res Treat2006-06-01T00:00:002006Overexpression of IGFBP5, but not IGFBP3, correlates with the histologic grade of human diffuse glioma: a tissue microarray and immunohistochemical study.16865597Varadhachary GR, Tamm EP, Abbruzzese JL, Xiong HQ, Crane CH, Wang H, Lee JE, Pisters PW, Evans DB, Wolff RAAnnals of surgical oncologyBorderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol. 2006 Aug; 13(8):1035-46.Ann Surg Oncol2006-07-24T00:00:002006Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy.17197919Wu TT, Chirieac LR, Abraham SC, Krasinskas AM, Wang H, Rashid A, Correa AM, Hofstetter WL, Ajani JA, Swisher SGThe American journal of surgical pathologyExcellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome. Am J Surg Pathol. 2007 Jan; 31(1):58-64.Am J Surg Pathol2007-01-01T00:00:002007Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome.17383522Tseng JF, Pisters PW, Lee JE, Wang H, Gomez HF, Sun CC, Evans DBSurgeryThe learning curve in pancreatic surgery. Surgery. 2007 Apr; 141(4):456-63.Surgery2007-01-22T00:00:002007The learning curve in pancreatic surgery.18176935Wei Y, Xia W, Zhang Z, Liu J, Wang H, Adsay NV, Albarracin C, Yu D, Abbruzzese JL, Mills GB, Bast RC, Hortobagyi GN, Hung MCMolecular carcinogenesisLoss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers. Mol Carcinog. 2008 Sep; 47(9):701-6.Mol Carcinog2008-09-01T00:00:002008Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers.18182745Blazer DG, Ramirez PT, Wang H, Fleming JBJOP : Journal of the pancreasDistal pancreatectomy for isolated metastasis of endometrial carcinoma to the pancreas. JOP. 2008 Jan 08; 9(1):56-60.JOP2008-01-08T00:00:002008Distal pancreatectomy for isolated metastasis of endometrial carcinoma to the pancreas.18256882Hwang RF, Wang H, Lara A, Gomez H, Chang T, Sieffert N, Moon Y, Ram S, Zimmerman S, Lee JH, Pisters PW, Tamm EP, Fleming JB, Abbruzzese JL, Evans DBAnnals of surgical oncologyDevelopment of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer. Ann Surg Oncol. 2008 May; 15(5):1356-66.Ann Surg Oncol2008-02-07T00:00:002008Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer.18376310Baker AF, Koh MY, Williams RR, James B, Wang H, Tate WR, Gallegos A, Von Hoff DD, Han H, Powis GPancreasIdentification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer. Pancreas. 2008 Mar; 36(2):178-86.Pancreas2008-03-01T00:00:002008Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.18496141Abraham SC, Wang H, Wang KK, Wu TTThe American journal of surgical pathologyPaget cells in the esophagus: assessment of their histopathologic features and near-universal association with underlying esophageal adenocarcinoma. Am J Surg Pathol. 2008 Jul; 32(7):1068-74.Am J Surg Pathol2008-07-01T00:00:002008Paget cells in the esophagus: assessment of their histopathologic features and near-universal association with underlying esophageal adenocarcinoma.18589369Katz MH, Mortenson MM, Wang H, Hwang R, Tamm EP, Staerkel G, Lee JH, Evans DB, Fleming JBJournal of the American College of SurgeonsDiagnosis and management of cystic neoplasms of the pancreas: an evidence-based approach. J Am Coll Surg. 2008 Jul; 207(1):106-20.J Am Coll Surg2008-04-24T00:00:002008Diagnosis and management of cystic neoplasms of the pancreas: an evidence-based approach.19194760Katz MH, Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA, Varadhachary G, Abbruzzese JL, Crane CH, Krishnan S, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DBAnnals of surgical oncologyLong-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol. 2009 Apr; 16(4):836-47.Ann Surg Oncol2009-02-05T00:00:002009Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma.19528349Chen J, Kobayashi M, Darmanin S, Qiao Y, Gully C, Zhao R, Kondo S, Wang H, Wang H, Yeung SC, Lee MHThe American journal of pathologyHypoxia-mediated up-regulation of Pim-1 contributes to solid tumor formation. Am J Pathol. 2009 Jul; 175(1):400-11.Am J Pathol2009-06-15T00:00:002009Hypoxia-mediated up-regulation of Pim-1 contributes to solid tumor formation.19541433Yu W, Liu J, Xiong X, Ai Y, Wang HPathology, research and practiceExpression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication. Pathol Res Pract. 2009; 205(10):709-15.Pathol Res Pract2009-06-21T00:00:002009Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication.19584296Arumugam T, Ramachandran V, Fournier KF, Wang H, Marquis L, Abbruzzese JL, Gallick GE, Logsdon CD, McConkey DJ, Choi WCancer researchEpithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res. 2009 Jul 15; 69(14):5820-8.Cancer Res2009-07-07T00:00:002009Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer.19876027Kim MP, Evans DB, Wang H, Abbruzzese JL, Fleming JB, Gallick GENature protocolsGeneration of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice. Nat Protoc. 2009; 4(11):1670-80.Nat Protoc2009-10-29T00:00:002009Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice.20423983Yang G, Chang B, Yang F, Guo X, Cai KQ, Xiao XS, Wang H, Sen S, Hung MC, Mills GB, Chang S, Multani AS, Mercado-Uribe I, Liu JClinical cancer research : an official journal of the American Association for Cancer ResearchAurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2. Clin Cancer Res. 2010 Jun 15; 16(12):3171-81.Clin Cancer Res2010-04-27T00:00:002010Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2.20970364Yang Q, Wang H, Cho HY, Jung SJ, Kim KR, Ro JY, Shen SSAnnals of diagnostic pathologyCarcinoma of m?llerian origin presenting as colorectal cancer: a clinicopathologic study of 13 Cases. Ann Diagn Pathol. 2011 Feb; 15(1):12-8.Ann Diagn Pathol2010-10-20T00:00:002010Carcinoma of m?llerian origin presenting as colorectal cancer: a clinicopathologic study of 13 Cases.21135113Su CH, Zhao R, Zhang F, Qu C, Chen B, Feng YH, Phan L, Chen J, Wang H, Wang H, Yeung SC, Lee MHCancer research14-3-3sigma exerts tumor-suppressor activity mediated by regulation of COP1 stability. Cancer Res. 2011 Feb 01; 71(3):884-94.Cancer Res2010-12-06T00:00:00201014-3-3sigma exerts tumor-suppressor activity mediated by regulation of COP1 stability.21531815Varadhachary GR, Spector Y, Abbruzzese JL, Rosenwald S, Wang H, Aharonov R, Carlson HR, Cohen D, Karanth S, Macinskas J, Lenzi R, Chajut A, Edmonston TB, Raber MNClinical cancer research : an official journal of the American Association for Cancer ResearchProspective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary. Clin Cancer Res. 2011 Jun 15; 17(12):4063-70.Clin Cancer Res2011-04-29T00:00:002011Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary.21695188Kim MP, Fleming JB, Wang H, Abbruzzese JL, Choi W, Kopetz S, McConkey DJ, Evans DB, Gallick GEPloS oneALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma. PLoS One. 2011; 6(6):e20636.PLoS One2011-06-13T00:00:002011ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.21735446Estrella JS, Rashid A, Fleming JB, Katz MH, Lee JE, Wolf RA, Varadhachary GR, Pisters PW, Abdalla EK, Vauthey JN, Wang H, Gomez HF, Evans DB, Abbruzzese JL, Wang HCancerPost-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation. Cancer. 2012 Jan 01; 118(1):268-77.Cancer2011-07-06T00:00:002011Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation.22050964Zhao Q, Rashid A, Gong Y, Katz MH, Lee JE, Wolf R, Balachandran A, Varadhachary GR, Pisters PW, Wang H, Gomez HF, Abbruzzese JL, Fleming JB, Wang HAnnals of diagnostic pathologyPathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis. Ann Diagn Pathol. 2012 Jan; 16(1):29-37.Ann Diagn Pathol2011-11-03T00:00:002011Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis.22082777Dhingra S, Wang HAnnals of diagnostic pathologyNonneoplastic signet-ring cell change in gastrointestinal and biliary tracts: a pitfall for overdiagnosis. Ann Diagn Pathol. 2011 Dec; 15(6):490-6.Ann Diagn Pathol2011-12-01T00:00:002011Nonneoplastic signet-ring cell change in gastrointestinal and biliary tracts: a pitfall for overdiagnosis.22136834Dickson PV, Rich TA, Xing Y, Cote GJ, Wang H, Perrier ND, Evans DB, Lee JE, Grubbs EGSurgeryAchieving eugastrinemia in MEN1 patients: both duodenal inspection and formal lymph node dissection are important. Surgery. 2011 Dec; 150(6):1143-52.Surgery2011-12-01T00:00:002011Achieving eugastrinemia in MEN1 patients: both duodenal inspection and formal lymph node dissection are important.22301496Chatterjee D, Rashid A, Wang H, Katz MH, Wolff RA, Varadhachary GR, Lee JE, Pisters PW, Gomez HF, Abbruzzese JL, Fleming JB, Wang HThe American journal of surgical pathologyTumor invasion of muscular vessels predicts poor prognosis in patients with pancreatic ductal adenocarcinoma who have received neoadjuvant therapy and pancreaticoduodenectomy. Am J Surg Pathol. 2012 Apr; 36(4):552-9.Am J Surg Pathol2012-04-01T00:00:002012Tumor invasion of muscular vessels predicts poor prognosis in patients with pancreatic ductal adenocarcinoma who have received neoadjuvant therapy and pancreaticoduodenectomy.22406536Daniluk J, Liu Y, Deng D, Chu J, Huang H, Gaiser S, Cruz-Monserrate Z, Wang H, Ji B, Logsdon CDThe Journal of clinical investigationAn NF-?B pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice. J Clin Invest. 2012 Apr; 122(4):1519-28.J Clin Invest2012-03-12T00:00:002012An NF-?B pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice.22439934Wang Y, Ding Q, Yen CJ, Xia W, Izzo JG, Lang JY, Li CW, Hsu JL, Miller SA, Wang X, Lee DF, Hsu JM, Huo L, Labaff AM, Liu D, Huang TH, Lai CC, Tsai FJ, Chang WC, Chen CH, Wu TT, Buttar NS, Wang KK, Wu Y, Wang H, Ajani J, Hung MCCancer cellThe crosstalk of mTOR/S6K1 and Hedgehog pathways. Cancer Cell. 2012 Mar 20; 21(3):374-87.Cancer Cell2012-03-20T00:00:002012The crosstalk of mTOR/S6K1 and Hedgehog pathways.22900040Song S, Ji B, Ramachandran V, Wang H, Hafley M, Logsdon C, Bresalier RSPloS oneOverexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding Ras and activating Ras signaling. PLoS One. 2012; 7(8):e42699.PLoS One2012-08-10T00:00:002012Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding Ras and activating Ras signaling.23083799Bilen MA, Kim J, Wang H, Tu SMClinical genitourinary cancerCixutumumab-associated pancolitis in a patient with prostate cancer. Clin Genitourin Cancer. 2013 Jun; 11(2):207-10.Clin Genitourin Cancer2012-10-17T00:00:002012Cixutumumab-associated pancolitis in a patient with prostate cancer.23134473Li L, Othman M, Rashid A, Wang H, Li Z, Katz MH, Lee JE, Pisters PW, Abbruzzese JL, Fleming JB, Wang HHistopathologySolid pseudopapillary neoplasm of the pancreas with prominent atypical multinucleated giant tumour cells. Histopathology. 2013 Feb; 62(3):465-71.Histopathology2012-11-08T00:00:002012Solid pseudopapillary neoplasm of the pancreas with prominent atypical multinucleated giant tumour cells.23340292Chang Z, Li Z, Wang X, Kang Y, Yuan Y, Niu J, Wang H, Chatterjee D, Fleming JB, Li M, Abbruzzese JL, Chiao PJClinical cancer research : an official journal of the American Association for Cancer ResearchDeciphering the mechanisms of tumorigenesis in human pancreatic ductal epithelial cells. Clin Cancer Res. 2013 Feb 01; 19(3):549-59.Clin Cancer Res2013-01-22T00:00:002013Deciphering the mechanisms of tumorigenesis in human pancreatic ductal epithelial cells.23776447Overman MJ, Zhang J, Kopetz S, Davies M, Jiang ZQ, Zhi-Qin J, Stemke-Hale K, R?mmele P, Pilarsky C, Gr?tzmann R, Hamilton S, Hwang R, Abbruzzese JL, Varadhachary G, Broom B, Wang HPloS oneGene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcome. PLoS One. 2013; 8(6):e65144.PLoS One2013-06-11T00:00:002013Gene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcome.24241967Tzeng CW, Tran Cao HS, Lee JE, Pisters PW, Varadhachary GR, Wolff RA, Abbruzzese JL, Crane CH, Evans DB, Wang H, Abbott DE, Vauthey JN, Aloia TA, Fleming JB, Katz MHJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractTreatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival. J Gastrointest Surg. 2014 Jan; 18(1):16-24; discussion 24-5.J Gastrointest Surg2013-11-16T00:00:002013Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival.24746206Guo R, Overman M, Chatterjee D, Rashid A, Shroff S, Wang H, Katz MH, Fleming JB, Varadhachary GR, Abbruzzese JL, Wang HHuman pathologyAberrant expression of p53, p21, cyclin D1, and Bcl2 and their clinicopathological correlation in ampullary adenocarcinoma. Hum Pathol. 2014 May; 45(5):1015-23.Hum Pathol2014-01-17T00:00:002014Aberrant expression of p53, p21, cyclin D1, and Bcl2 and their clinicopathological correlation in ampullary adenocarcinoma.25076292Estrella JS, Broaddus RR, Mathews A, Milton DR, Yao JC, Wang H, Rashid AArchives of pathology & laboratory medicineProgesterone receptor and PTEN expression predict survival in patients with low- and intermediate-grade pancreatic neuroendocrine tumors. Arch Pathol Lab Med. 2014 Aug; 138(8):1027-36.Arch Pathol Lab Med2014-08-01T00:00:002014Progesterone receptor and PTEN expression predict survival in patients with low- and intermediate-grade pancreatic neuroendocrine tumors.Authorship 2650832Authorship 2657401Authorship 2668848Authorship 2673423Authorship 2675604Authorship 2691523Authorship 2699205Authorship 27050910Authorship 2715889Authorship 2718677Authorship 2719759Authorship 2720311211046114Rowlands JC, Wang H, Hakkak R, Ronis MJ, Strobel HW, Badger TMThe Journal of pharmacology and experimental therapeuticsChronic intragastric infusion of ethanol-containing diets induces CYP3A9 while decreasing CYP3A2 in male rats. J Pharmacol Exp Ther. 2000 Nov; 295(2):747-52.J Pharmacol Exp Ther2000-11-01T00:00:002000Chronic intragastric infusion of ethanol-containing diets induces CYP3A9 while decreasing CYP3A2 in male rats.12482627Wang H, Actor JK, Indrigo J, Olsen M, Dasgupta AClinica chimica acta; international journal of clinical chemistryAsian and Siberian ginseng as a potential modulator of immune function: an in vitro cytokine study using mouse macrophages. Clin Chim Acta. 2003 Jan; 327(1-2):123-8.Clin Chim Acta2003-01-01T00:00:002003Asian and Siberian ginseng as a potential modulator of immune function: an in vitro cytokine study using mouse macrophages.17211865Wang KL, Wu TT, Choi IS, Wang H, Resetkova E, Reseetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CTCancerExpression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Cancer. 2007 Feb 15; 109(4):658-67.Cancer2007-02-15T00:00:002007Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.17973266Yuan P, Wang L, Wei D, Zhang J, Jia Z, Li Q, Le X, Wang H, Yao J, Xie KCancerTherapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer. Cancer. 2007 Dec 15; 110(12):2682-90.Cancer2007-12-15T00:00:002007Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer.17985187Lim SJ, Feig BW, Wang H, Hunt KK, Rodriguez-Bigas MA, Skibber JM, Ellis V, Cleary K, Chang GJAnnals of surgical oncologySentinel lymph node evaluation does not improve staging accuracy in colon cancer. Ann Surg Oncol. 2008 Jan; 15(1):46-51.Ann Surg Oncol2007-11-06T00:00:002007Sentinel lymph node evaluation does not improve staging accuracy in colon cancer.19501586Ji B, Tsou L, Wang H, Gaiser S, Chang DZ, Daniluk J, Bi Y, Grote T, Longnecker DS, Logsdon CDGastroenterologyRas activity levels control the development of pancreatic diseases. Gastroenterology. 2009 Sep; 137(3):1072-82, 1082.e1-6.Gastroenterology2009-06-06T00:00:002009Ras activity levels control the development of pancreatic diseases.21747314Arumugam T, Brandt W, Ramachandran V, Moore TT, Wang H, May FE, Westley BR, Hwang RF, Logsdon CDPancreasTrefoil factor 1 stimulates both pancreatic cancer and stellate cells and increases metastasis. Pancreas. 2011 Aug; 40(6):815-22.Pancreas2011-08-01T00:00:002011Trefoil factor 1 stimulates both pancreatic cancer and stellate cells and increases metastasis.22264792Ling J, Kang Y, Zhao R, Xia Q, Lee DF, Chang Z, Li J, Peng B, Fleming JB, Wang H, Liu J, Lemischka IR, Hung MC, Chiao PJCancer cellKrasG12D-induced IKK2/?/NF-?B activation by IL-1a and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell. 2012 Jan 17; 21(1):105-20.Cancer Cell2012-01-17T00:00:002012KrasG12D-induced IKK2/?/NF-?B activation by IL-1a and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma.23958541Philip B, Roland CL, Daniluk J, Liu Y, Chatterjee D, Gomez SB, Ji B, Huang H, Wang H, Fleming JB, Logsdon CD, Cruz-Monserrate ZGastroenterologyA high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice. Gastroenterology. 2013 Dec; 145(6):1449-58.Gastroenterology2013-08-16T00:00:002013A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice.24168499Shroff S, Overman MJ, Rashid A, Shroff RT, Wang H, Chatterjee D, Katz MH, Lee JE, Wolff RA, Abbruzzese JL, Fleming JB, Wang HArchives of pathology & laboratory medicineThe expression of PTEN is associated with improved prognosis in patients with ampullary adenocarcinoma after pancreaticoduodenectomy. Arch Pathol Lab Med. 2013 Nov; 137(11):1619-26.Arch Pathol Lab Med2013-11-01T00:00:002013The expression of PTEN is associated with improved prognosis in patients with ampullary adenocarcinoma after pancreaticoduodenectomy.24418850Estrella JS, Li L, Rashid A, Wang H, Katz MH, Fleming JB, Abbruzzese JL, Wang HThe American journal of surgical pathologySolid pseudopapillary neoplasm of the pancreas: clinicopathologic and survival analyses of 64 cases from a single institution. Am J Surg Pathol. 2014 Feb; 38(2):147-57.Am J Surg Pathol2014-02-01T00:00:002014Solid pseudopapillary neoplasm of the pancreas: clinicopathologic and survival analyses of 64 cases from a single institution.24569947Christians KK, Tsai S, Mahmoud A, Ritch P, Thomas JP, Wiebe L, Kelly T, Erickson B, Wang H, Evans DB, George BThe oncologistNeoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm? Oncologist. 2014 Mar; 19(3):266-74.Oncologist2014-02-25T00:00:002014Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm?Authorship 2728752Authorship 2733334Authorship 27370011Authorship 2739629Authorship 27417617Authorship 27470414Authorship 27482510Authorship 2753012216360380Mullen JT, Wang H, Yao JC, Lee JH, Perrier ND, Pisters PW, Lee JE, Evans DBSurgeryCarcinoid tumors of the duodenum. Surgery. 2005 Dec; 138(6):971-7; discussion 977-8.Surgery2005-12-01T00:00:002005Carcinoid tumors of the duodenum.17592291Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH, Hwang R, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DBAnnals of surgeryImpact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg. 2007 Jul; 246(1):52-60.Ann Surg2007-07-01T00:00:002007Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.20628027Peng L, Liang J, Wang H, Song X, Rashid A, Gomez HF, Corley LJ, Abbruzzese JL, Fleming JB, Evans DB, Wang HClinical cancer research : an official journal of the American Association for Cancer ResearchHigh levels of nucleolar expression of nucleolin are associated with better prognosis in patients with stage II pancreatic ductal adenocarcinoma. Clin Cancer Res. 2010 Jul 15; 16(14):3734-42.Clin Cancer Res2010-07-13T00:00:002010High levels of nucleolar expression of nucleolin are associated with better prognosis in patients with stage II pancreatic ductal adenocarcinoma.20732965Liang JJ, Zhu S, Bruggeman R, Zaino RJ, Evans DB, Fleming JB, Gomez HF, Zander DS, Wang HCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyHigh levels of expression of human stromal cell-derived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2010 Oct; 19(10):2598-604.Cancer Epidemiol Biomarkers Prev2010-08-23T00:00:002010High levels of expression of human stromal cell-derived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.21317535Zhao R, Yeung SC, Chen J, Iwakuma T, Su CH, Chen B, Qu C, Zhang F, Chen YT, Lin YL, Lee DF, Jin F, Zhu R, Shaikenov T, Sarbassov D, Sahin A, Wang H, Wang H, Lai CC, Tsai FJ, Lozano G, Lee MHThe Journal of clinical investigationSubunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers. J Clin Invest. 2011 Mar; 121(3):851-65.J Clin Invest2011-02-07T00:00:002011Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers.22301497Chatterjee D, Katz MH, Rashid A, Wang H, Iuga AC, Varadhachary GR, Wolff RA, Lee JE, Pisters PW, Crane CH, Gomez HF, Abbruzzese JL, Fleming JB, Wang HThe American journal of surgical pathologyPerineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. Am J Surg Pathol. 2012 Mar; 36(3):409-17.Am J Surg Pathol2012-03-01T00:00:002012Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma.23260327Foo WC, Rashid A, Wang H, Katz MH, Lee JE, Pisters PW, Wolff RA, Abbruzzese JL, Fleming JB, Wang HHuman pathologyLoss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma. Hum Pathol. 2013 Jun; 44(6):1024-30.Hum Pathol2012-12-20T00:00:002012Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma.24954535Kapoor A, Yao W, Ying H, Hua S, Liewen A, Wang Q, Zhong Y, Wu CJ, Sadanandam A, Hu B, Chang Q, Chu GC, Al-Khalil R, Jiang S, Xia H, Fletcher-Sananikone E, Lim C, Horwitz GI, Viale A, Pettazzoni P, Sanchez N, Wang H, Protopopov A, Zhang J, Heffernan T, Johnson RL, Chin L, Wang YA, Draetta G, DePinho RACellYap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer. Cell. 2014 Jul 03; 158(1):185-197.Cell2014-06-19T00:00:002014Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer.24928781Roland CL, Arumugam T, Deng D, Liu SH, Philip B, Gomez S, Burns WR, Ramachandran V, Wang H, Cruz-Monserrate Z, Logsdon CDCancer researchCell surface lactate receptor GPR81 is crucial for cancer cell survival. Cancer Res. 2014 Sep 15; 74(18):5301-10.Cancer Res2014-06-13T00:00:002014Cell surface lactate receptor GPR81 is crucial for cancer cell survival.25029561Chang Z, Ju H, Ling J, Zhuang Z, Li Z, Wang H, Fleming JB, Freeman JW, Yu D, Huang P, Chiao PJPloS oneCooperativity of oncogenic K-ras and downregulated p16/INK4A in human pancreatic tumorigenesis. PLoS One. 2014; 9(7):e101452.PLoS One2014-07-16T00:00:002014Cooperativity of oncogenic K-ras and downregulated p16/INK4A in human pancreatic tumorigenesis.25193509Gonzalez-Villasana V, Rodriguez-Aguayo C, Arumugam T, Cruz-Monserrate Z, Fuentes-Mattei E, Deng D, Hwang RF, Wang H, Ivan C, Garza RJ, Cohen E, Gao H, Armaiz-Pena GN, Del C Monroig-Bosque P, Philip B, Rashed MH, Aslan B, Erdogan MA, Gutierrez-Puente Y, Ozpolat B, Reuben JM, Sood AK, Logsdon C, Lopez-Berestein GMolecular cancer therapeuticsBisphosphonates inhibit stellate cell activity and enhance antitumor effects of nanoparticle albumin-bound paclitaxel in pancreatic ductal adenocarcinoma. Mol Cancer Ther. 2014 Nov; 13(11):2583-94.Mol Cancer Ther2014-09-05T00:00:002014Bisphosphonates inhibit stellate cell activity and enhance antitumor effects of nanoparticle albumin-bound paclitaxel in pancreatic ductal adenocarcinoma.25264609Kang Y, Ling J, Suzuki R, Roife D, Chopin-Laly X, Truty MJ, Chatterjee D, Wang H, Thomas RM, Katz MH, Chiao PJ, Fleming JBPloS oneSMAD4 regulates cell motility through transcription of N-cadherin in human pancreatic ductal epithelium. PLoS One. 2014; 9(9):e107948.PLoS One2014-09-29T00:00:002014SMAD4 regulates cell motility through transcription of N-cadherin in human pancreatic ductal epithelium.25336691Li X, Truty MA, Kang Y, Chopin-Laly X, Zhang R, Roife D, Chatterjee D, Lin E, Thomas RM, Wang H, Katz MH, Fleming JBClinical cancer research : an official journal of the American Association for Cancer ResearchExtracellular lumican inhibits pancreatic cancer cell growth and is associated with prolonged survival after surgery. Clin Cancer Res. 2014 Dec 15; 20(24):6529-40.Clin Cancer Res2014-10-21T00:00:002014Extracellular lumican inhibits pancreatic cancer cell growth and is associated with prolonged survival after surgery.25352267Roland CL, Yang AD, Katz MH, Chatterjee D, Wang H, Lin H, Vauthey JN, Pisters PW, Varadhachary GR, Wolff RA, Crane CH, Lee JE, Fleming JBAnnals of surgical oncologyNeoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancer. Ann Surg Oncol. 2015 Apr; 22(4):1168-75.Ann Surg Oncol2014-10-29T00:00:002014Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancer.25395170Chen J, Shin JH, Zhao R, Phan L, Wang H, Xue Y, Post SM, Ho Choi H, Chen JS, Wang E, Zhou Z, Tseng C, Gully C, Velazquez-Torres G, Fuentes-Mattei E, Yeung G, Qiao Y, Chou PC, Su CH, Hsieh YC, Hsu SL, Ohshiro K, Shaikenov T, Wang H, Yeung SC, Lee MHNature communicationsCSN6 drives carcinogenesis by positively regulating Myc stability. Nat Commun. 2014 Nov 14; 5:5384.Nat Commun2014-11-14T00:00:002014CSN6 drives carcinogenesis by positively regulating Myc stability.25427073Koay EJ, Baio FE, Ondari A, Truty MJ, Cristini V, Thomas RM, Chen R, Chatterjee D, Kang Y, Zhang J, Court L, Bhosale PR, Tamm EP, Qayyum A, Crane CH, Javle M, Katz MH, Gottumukkala VN, Rozner MA, Shen H, Lee JE, Wang H, Chen Y, Plunkett W, Abbruzzese JL, Wolff RA, Maitra A, Ferrari M, Varadhachary GR, Fleming JBPhysical biologyIntra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer. Phys Biol. 2014 Nov 26; 11(6):065002.Phys Biol2014-11-26T00:00:002014Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer.25485535Kang Y, Zhang R, Suzuki R, Li SQ, Roife D, Truty MJ, Chatterjee D, Thomas RM, Cardwell J, Wang Y, Wang H, Katz MH, Fleming JBLaboratory investigation; a journal of technical methods and pathologyTwo-dimensional culture of human pancreatic adenocarcinoma cells results in an irreversible transition from epithelial to mesenchymal phenotype. Lab Invest. 2015 Feb; 95(2):207-22.Lab Invest2014-12-08T00:00:002014Two-dimensional culture of human pancreatic adenocarcinoma cells results in an irreversible transition from epithelial to mesenchymal phenotype.25989273Schueneman A, Goggins M, Ensor J, Saka B, Neishaboori N, Lee S, Maitra A, Varadhachary G, Rezaee N, Wolfgang C, Adsay V, Wang H, Overman MJBritish journal of cancerValidation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma. Br J Cancer. 2015 Jun 30; 113(1):64-8.Br J Cancer2015-05-19T00:00:002015Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma.25995340Wang H, Maitra A, Wang HClinical cancer research : an official journal of the American Association for Cancer ResearchObesity, Intrapancreatic Fatty Infiltration, and Pancreatic Cancer. Clin Cancer Res. 2015 Aug 01; 21(15):3369-71.Clin Cancer Res2015-05-20T00:00:002015Obesity, Intrapancreatic Fatty Infiltration, and Pancreatic Cancer.26025324Capello M, Lee M, Wang H, Babel I, Katz MH, Fleming JB, Maitra A, Wang H, Tian W, Taguchi A, Hanash SMJournal of the National Cancer InstituteCarboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma. J Natl Cancer Inst. 2015 Aug; 107(8).J Natl Cancer Inst2015-05-29T00:00:002015Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma.26126726Fogelman D, Sugar EA, Oliver G, Shah N, Klein A, Alewine C, Wang H, Javle M, Shroff R, Wolff RA, Abbruzzese JL, Laheru D, Diaz LACancer chemotherapy and pharmacologyFamily history as a marker of platinum sensitivity in pancreatic adenocarcinoma. Cancer Chemother Pharmacol. 2015 Sep; 76(3):489-498.Cancer Chemother Pharmacol2015-07-01T00:00:002015Family history as a marker of platinum sensitivity in pancreatic adenocarcinoma.26165226Xia M, Overman MJ, Rashid A, Chatterjee D, Wang H, Katz MH, Fleming JB, Lee JE, Varadhachary GR, Wolff RA, Wang HHuman pathologyExpression and clinical significance of epidermal growth factor receptor and insulin-like growth factor receptor 1 in patients with ampullary adenocarcinoma. Hum Pathol. 2015 Sep; 46(9):1315-22.Hum Pathol2015-05-30T00:00:002015Expression and clinical significance of epidermal growth factor receptor and insulin-like growth factor receptor 1 in patients with ampullary adenocarcinoma.26166470Estrella JS, Wang H, Bhosale PR, Evans HL, Abraham SCPancreasMalignant Solitary Fibrous Tumor of the Pancreas. Pancreas. 2015 Aug; 44(6):988-94.Pancreas2015-08-01T00:00:002015Malignant Solitary Fibrous Tumor of the Pancreas.26200098Liu L, Katz MH, Lee SM, Fischer LK, Prakash L, Parker N, Wang H, Varadhachary GR, Wolff RA, Lee JE, Pisters PW, Maitra A, Fleming JB, Estrella J, Rashid A, Wang HThe American journal of surgical pathologySuperior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma. Am J Surg Pathol. 2015 Oct; 39(10):1395-403.Am J Surg Pathol2015-10-01T00:00:002015Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.14744083Wang H, Shen SS, Wang H, Diwan AH, Zhang W, Fuller GN, Prieto VGJournal of cutaneous pathologyExpression of insulin-like growth factor-binding protein 2 in melanocytic lesions. J Cutan Pathol. 2003 Nov; 30(10):599-605.J Cutan Pathol2003-11-01T00:00:002003Expression of insulin-like growth factor-binding protein 2 in melanocytic lesions.74Professor10Assistant Professor14Associate Professor18981001Liang JJ, Wang H, Rashid A, Tan TH, Hwang RF, Hamilton SR, Abbruzzese JL, Evans DB, Wang HClinical cancer research : an official journal of the American Association for Cancer ResearchExpression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. Clin Cancer Res. 2008 Nov 01; 14(21):7043-9.Clin Cancer Res2008-11-01T00:00:002008Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.Authorship 37410011Authorship 3741019Authorship 3741063Authorship 37410711Authorship 3741088Authorship 37410912Authorship 37411024Authorship 3741246Authorship 3741341Authorship 37413522Authorship 3741408Authorship 3741435Authorship 37414410Authorship 37414815Authorship 3741497Authorship 374152718640930Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Wang H, Cleary KR, Staerkel GA, Charnsangavej C, Lano EA, Ho L, Lenzi R, Abbruzzese JL, Wolff RAJournal of clinical oncology : official journal of the American Society of Clinical OncologyPreoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol. 2008 Jul 20; 26(21):3496-502.J Clin Oncol2008-07-20T00:00:002008Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head.20586628Fang X, Gupta N, Shen SS, Tamboli P, Charnsangavej C, Rashid A, Wang HArchives of pathology & laboratory medicineIntraluminal polypoid metastasis of renal cell carcinoma in gallbladder mimicking gallbladder polyp. Arch Pathol Lab Med. 2010 Jul; 134(7):1003-9.Arch Pathol Lab Med2010-07-01T00:00:002010Intraluminal polypoid metastasis of renal cell carcinoma in gallbladder mimicking gallbladder polyp.20406923Overman MJ, Maru DM, Charnsangavej C, Loyer EM, Wang H, Pathak P, Eng C, Hoff PM, Vauthey JN, Wolff RA, Kopetz SJournal of clinical oncology : official journal of the American Society of Clinical OncologyOxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury. J Clin Oncol. 2010 May 20; 28(15):2549-55.J Clin Oncol2010-04-20T00:00:002010Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury.CHING-WEI DAVIDTZENGCHING-WEI DAVID TZENG12722TZENG, CHING-WEI DAVIDAssistant Professor20696914Peng B, Ling J, Lee AJ, Wang Z, Chang Z, Jin W, Kang Y, Zhang R, Shim D, Wang H, Fleming JB, Zheng H, Sun SC, Chiao PJProceedings of the National Academy of Sciences of the United States of AmericaDefective feedback regulation of NF-kappaB underlies Sjogren's syndrome in mice with mutated kappaB enhancers of the IkappaBalpha promoter. Proc Natl Acad Sci U S A. 2010 Aug 24; 107(34):15193-8.Proc Natl Acad Sci U S A2010-08-09T00:00:002010Defective feedback regulation of NF-kappaB underlies Sjogren's syndrome in mice with mutated kappaB enhancers of the IkappaBalpha promoter.22065318Katz MH, Wang H, Balachandran A, Bhosale P, Crane CH, Wang X, Pisters PW, Lee JE, Vauthey JN, Abdalla EK, Wolff R, Abbruzzese J, Varadhachary G, Chopin-Laly X, Charnsangavej C, Fleming JBJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractEffect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer. J Gastrointest Surg. 2012 Jan; 16(1):68-78; discussion 78-9.J Gastrointest Surg2011-11-08T00:00:002011Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer.22605518Katz MH, Fleming JB, Bhosale P, Varadhachary G, Lee JE, Wolff R, Wang H, Abbruzzese J, Pisters PW, Vauthey JN, Charnsangavej C, Tamm E, Crane CH, Balachandran ACancerResponse of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators. Cancer. 2012 Dec 01; 118(23):5749-56.Cancer2012-05-17T00:00:002012Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators.Authorship 841325Authorship 842096Authorship 842529Authorship 842622Authorship 843597Authorship 844320Authorship 844714Authorship 844786Authorship 845415Authorship 845966Authorship 846945Authorship 847820Authorship 849293Authorship 849707Authorship 849992Authorship 850307Authorship 852249Authorship 852644Authorship 852792Authorship 853057Authorship 854817Authorship 856779Authorship 857805Authorship 863090Authorship 863862Authorship 865267Authorship 866982Authorship 867382Authorship 867513Authorship 868079Neoadjuvant Treatment of Pancreatic Cancer. 727-740.Neoadjuvant Treatment of Pancreatic CancerAmerican Journal of Surgical PathologyValidation of a Proposed Tumor Regression Grading Scheme for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy as a Prognostic Indicator for Survival. American Journal of Surgical Pathology. Validation of a Proposed Tumor Regression Grading Scheme for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy as a Prognostic Indicator for SurvivalCell ReportsIn Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer. Cell Reports. 16:133-147.In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic CancerBMC CancerPerformance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma. BMC Cancer. 16.Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinomaPLoS OnePhase i trial of consolidative radiotherapy with concurrent bevacizumab, erlotinib and capecitabine for unresectable pancreatic cancer. PLoS One. 11.Phase i trial of consolidative radiotherapy with concurrent bevacizumab, erlotinib and capecitabine for unresectable pancreatic cancerCell ReportsAmpullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation. Cell Reports. 14:907-919.Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT DysregulationCancer ResearchFibulin-5 blocks microenvironmental ROS in pancreatic cancer. Cancer Research. 75:5058-5069.Fibulin-5 blocks microenvironmental ROS in pancreatic cancerHistopathologyThe number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy. Histopathology. The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomyCancer ResearchOncogenic functions of Gli1 in pancreatic adenocarcinoma are supported by its PRMT1-mediated methylation. Cancer Research. 76:7049-7058.Oncogenic functions of Gli1 in pancreatic adenocarcinoma are supported by its PRMT1-mediated methylationGutLong non-coding RNA CCAL regulates colorectal cancer progression by activating Wnt/β-catenin signalling pathway via suppression of activator protein 2α. Gut. Long non-coding RNA CCAL regulates colorectal cancer progression by activating Wnt/β-catenin signalling pathway via suppression of activator protein 2αCancer ResearchIGFBP2 activates the NF-κB pathway to drive epithelial-mesenchymal transition and invasive character in pancreatic ductal adenocarcinoma. Cancer Research. 76:6543-6554.IGFBP2 activates the NF-κB pathway to drive epithelial-mesenchymal transition and invasive character in pancreatic ductal adenocarcinomaMolecular Cancer TherapeuticsNew blocking antibodies against novel AGR2-C4.4A pathway reduce growth and metastasis of pancreatic tumors and increase survival in mice. Molecular Cancer Therapeutics. 14:941-951.New blocking antibodies against novel AGR2-C4.4A pathway reduce growth and metastasis of pancreatic tumors and increase survival in miceJournal of Gastrointestinal SurgeryPreoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma. Journal of Gastrointestinal Surgery. 1-11.Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal AdenocarcinomaNature CommunicationsThe ZNF304-integrin axis protects against anoikis in cancer. Nature Communications. 6.The ZNF304-integrin axis protects against anoikis in cancerPLoS OneHepatocyte Nuclear Factor 1A (HNF1A) as a possible tumor suppressor in pancreatic cancer. PLoS One. 10.Hepatocyte Nuclear Factor 1A (HNF1A) as a possible tumor suppressor in pancreatic cancerPLoS OneCancer of unknown primary in adolescents and young adults. PLoS One. 11.Cancer of unknown primary in adolescents and young adultsPLoS OnePrognostic and functional significance of MAP4K5 in pancreatic cancer. PLoS One. 11.Prognostic and functional significance of MAP4K5 in pancreatic cancerMargin status following pancreaticoduodenectomy for pancreatic adenocarcinoma. 611-623.Margin status following pancreaticoduodenectomy for pancreatic adenocarcinomaCancerBevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater. Cancer. Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vaterClinical Cancer ResearchRac1/Pak1/p38/MMP-2 axis regulates angiogenesis in ovarian cancer. Clinical Cancer Research. 21:2127-2137.Rac1/Pak1/p38/MMP-2 axis regulates angiogenesis in ovarian cancerSeminars in Cancer BiologyThe emerging roles of F-box proteins in pancreatic tumorigenesis. Seminars in Cancer Biology. 36:88-94.The emerging roles of F-box proteins in pancreatic tumorigenesisPLoS OneErratum. PLoS One. 8.ErratumNature CommunicationsNature Communications. 6.Nature CommunicationsClinical Cancer ResearchTransforming growth factor-β limits secretion of lumican by activated stellate cells within primary pancreatic adenocarcinoma tumors. Clinical Cancer Research. 22:4934-4946.Transforming growth factor-β limits secretion of lumican by activated stellate cells within primary pancreatic adenocarcinoma tumorsOncotargetQuantitative imaging to evaluate malignant potential of IPMNs. Oncotarget. 7:85776-85784.Quantitative imaging to evaluate malignant potential of IPMNsPancreasExpression of estrogen-induced genes and estrogen receptor β in pancreatic neuroendocrine tumors. Pancreas. Expression of estrogen-induced genes and estrogen receptor β in pancreatic neuroendocrine tumorsJournal of Gastrointestinal SurgeryRole and Operative Technique of Portal Venous Tumor Thrombectomy in Patients with Pancreatic Neuroendocrine Tumors. Journal of Gastrointestinal Surgery. Role and Operative Technique of Portal Venous Tumor Thrombectomy in Patients with Pancreatic Neuroendocrine TumorsCancerErratum. Cancer. 115:2024.ErratumBritish Journal of CancerReply. British Journal of Cancer. 103:1306.ReplyRare TumorsSquamoid cystosis of pancreatic ducts. Rare Tumors. 6:39-41.Squamoid cystosis of pancreatic ducts11880098Casella R, Nudell D, Cozzolino D, Wang H, Lipshultz LIUrologyPrimary testicular amyloidosis mimicking tumor in a cryptorchid testis. Urology. 2002 Mar; 59(3):445.Urology2002-03-01T00:00:002002Primary testicular amyloidosis mimicking tumor in a cryptorchid testis.15671555Heimberger AB, McGary EC, Suki D, Ruiz M, Wang H, Fuller GN, Bar-Eli MClinical cancer research : an official journal of the American Association for Cancer ResearchLoss of the AP-2alpha transcription factor is associated with the grade of human gliomas. Clin Cancer Res. 2005 Jan 01; 11(1):267-72.Clin Cancer Res2005-01-01T00:00:002005Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.16729015Wang H, Rosen DG, Wang H, Fuller GN, Zhang W, Liu JModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncInsulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types. Mod Pathol. 2006 Sep; 19(9):1149-56.Mod Pathol2006-05-26T00:00:002006Insulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types.19088020Dallas NA, Gray MJ, Xia L, Fan F, van Buren G, Gaur P, Samuel S, Lim SJ, Arumugam T, Ramachandran V, Wang H, Ellis LMClinical cancer research : an official journal of the American Association for Cancer ResearchNeuropilin-2-mediated tumor growth and angiogenesis in pancreatic adenocarcinoma. Clin Cancer Res. 2008 Dec 15; 14(24):8052-60.Clin Cancer Res2008-12-15T00:00:002008Neuropilin-2-mediated tumor growth and angiogenesis in pancreatic adenocarcinoma.19141650Wang H, Song X, Logsdon C, Zhou G, Evans DB, Abbruzzese JL, Hamilton SR, Tan TH, Wang HCancer researchProteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer. Cancer Res. 2009 Feb 01; 69(3):1063-70.Cancer Res2009-01-13T00:00:002009Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer.19237629Dong X, Jiao L, Li Y, Evans DB, Wang H, Hess KR, Abbruzzese JL, Li DJournal of clinical oncology : official journal of the American Society of Clinical OncologySignificant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer. J Clin Oncol. 2009 Apr 01; 27(10):1592-9.J Clin Oncol2009-02-23T00:00:002009Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer.20697255Maru DM, Kopetz S, Boonsirikamchai P, Agarwal A, Chun YS, Wang H, Abdalla EK, Kaur H, Charnsangavej C, Vauthey JN, Loyer EMThe American journal of surgical pathologyTumor thickness at the tumor-normal interface: a novel pathologic indicator of chemotherapy response in hepatic colorectal metastases. Am J Surg Pathol. 2010 Sep; 34(9):1287-94.Am J Surg Pathol2010-09-01T00:00:002010Tumor thickness at the tumor-normal interface: a novel pathologic indicator of chemotherapy response in hepatic colorectal metastases.D014670Anatomy591550.894166Ampulla of VaterD003138Disorders531450.897755Common Bile Duct NeoplasmsD010190Disorders69850490.284505Pancreatic NeoplasmsD021441Disorders30517220.439879Carcinoma, Pancreatic DuctalD000230Disorders102777770.261755AdenocarcinomaPathology22589701Lu W, Hu Y, Chen G, Chen Z, Zhang H, Wang F, Feng L, Pelicano H, Wang H, Keating MJ, Liu J, McKeehan W, Wang H, Luo Y, Huang PPLoS biologyNovel role of NOX in supporting aerobic glycolysis in cancer cells with mitochondrial dysfunction and as a potential target for cancer therapy. PLoS Biol. 2012; 10(5):e1001326.PLoS Biol2012-05-08T00:00:002012Novel role of NOX in supporting aerobic glycolysis in cancer cells with mitochondrial dysfunction and as a potential target for cancer therapy.23857777Zhang Y, Yang J, Cui X, Chen Y, Zhu VF, Hagan JP, Wang H, Yu X, Hodges SE, Fang J, Chiao PJ, Logsdon CD, Fisher WE, Brunicardi FC, Chen C, Yao Q, Fernandez-Zapico ME, Li MEMBO molecular medicineA novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth. EMBO Mol Med. 2013 Sep; 5(9):1322-34.EMBO Mol Med2013-07-16T00:00:002013A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth.18936472Blazer DG, Kishi Y, Maru DM, Kopetz S, Chun YS, Overman MJ, Fogelman D, Eng C, Chang DZ, Wang H, Zorzi D, Ribero D, Ellis LM, Glover KY, Wolff RA, Curley SA, Abdalla EK, Vauthey JNJournal of clinical oncology : official journal of the American Society of Clinical OncologyPathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol. 2008 Nov 20; 26(33):5344-51.J Clin Oncol2008-10-20T00:00:002008Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.17960603Ribero D, Wang H, Donadon M, Zorzi D, Thomas MB, Eng C, Chang DZ, Curley SA, Abdalla EK, Ellis LM, Vauthey JNCancerBevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer. 2007 Dec 15; 110(12):2761-7.Cancer2007-12-15T00:00:002007Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases.23232580Bhosale P, Balachandran A, Wang H, Wei W, Hwang RF, Fleming JB, Varadhachary G, Charnsangavej C, Tamm EAbdominal imagingCT imaging features of acinar cell carcinoma and its hepatic metastases. Abdom Imaging. 2013 Dec; 38(6):1383-90.Abdom Imaging2013-12-01T00:00:002013CT imaging features of acinar cell carcinoma and its hepatic metastases.true1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professor24362026Wang H, Chen Y, Lin P, Li L, Zhou G, Liu G, Logsdon C, Jin J, Abbruzzese JL, Tan TH, Wang HThe Journal of biological chemistryThe CUL7/F-box and WD repeat domain containing 8 (CUL7/Fbxw8) ubiquitin ligase promotes degradation of hematopoietic progenitor kinase 1. J Biol Chem. 2014 Feb 14; 289(7):4009-17.J Biol Chem2013-12-20T00:00:002013The CUL7/F-box and WD repeat domain containing 8 (CUL7/Fbxw8) ubiquitin ligase promotes degradation of hematopoietic progenitor kinase 1.